Valuation Alcon Inc. Sao Paulo
Stocks
A2LC34
BRA2LCBDR004
Medical Equipment, Supplies & Distribution
|
Market Closed -
Sao Paulo
09:01:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 38.00 BRL | +6.98% |
|
-.--% | -15.56% |
| 10-02 | AlphaValue/Baader Europe Upgrades Alcon to Buy | MT |
| 09-28 | Alcon Inc. Launches Systane PRO PRESERVATIVE-FREE in Canada | CI |
Company Valuation: Alcon Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 43,286 | 33,596 | 38,446 | 41,934 | 39,316 | 30,802 | - | - |
| Change | - | -22.39% | 14.43% | 9.07% | -6.24% | -21.66% | - | - |
| Enterprise Value (EV) 1 | 46,197 | 37,296 | 42,046 | 44,734 | 42,526 | 33,377 | 32,286 | 30,829 |
| Change | - | -19.27% | 12.73% | 6.39% | -4.93% | -21.52% | -3.27% | -4.51% |
| P/E | 116x | 100x | 39.8x | 41.4x | 40.4x | 37x | 22.7x | 19x |
| PBR | 2.25x | 1.71x | 1.86x | 1.94x | 1.79x | 1.43x | 1.36x | 1.27x |
| PEG | - | -9.5x | 0x | 9.02x | -11.83x | -2.9x | 0.4x | 1x |
| Capitalization / Revenue | 5.22x | 3.85x | 4.07x | 4.23x | 3.78x | 2.78x | 2.62x | 2.46x |
| EV / Revenue | 5.57x | 4.28x | 4.45x | 4.51x | 4.09x | 3.01x | 2.74x | 2.46x |
| EV / EBITDA | 25.7x | 20.8x | 18.1x | 17.9x | 15.9x | 11.3x | 9.93x | 8.64x |
| EV / EBIT | 32x | 23.7x | 22.7x | 22.1x | 20.9x | 14.3x | 12.5x | 10.7x |
| EV / FCF | 71.6x | 64.2x | 57.6x | 27.9x | 24.5x | 22.2x | 18.5x | 15.8x |
| FCF Yield | 1.4% | 1.56% | 1.74% | 3.59% | 4.08% | 4.5% | 5.42% | 6.32% |
| Dividend per Share 2 | 0.2159 | 0.2239 | 0.273 | 0.3138 | 0.362 | 0.3716 | 0.4155 | 0.4714 |
| Rate of return | 0.24% | 0.33% | 0.35% | 0.37% | 0.45% | 0.58% | 0.65% | 0.74% |
| EPS 2 | 0.76 | 0.68 | 1.96 | 2.05 | 1.98 | 1.724 | 2.809 | 3.353 |
| Distribution rate | 28.4% | 32.9% | 13.9% | 15.3% | 18.3% | 21.5% | 14.8% | 14.1% |
| Net sales 1 | 8,291 | 8,717 | 9,455 | 9,911 | 10,401 | 11,087 | 11,769 | 12,517 |
| EBITDA 1 | 1,799 | 1,795 | 2,325 | 2,502 | 2,677 | 2,963 | 3,253 | 3,567 |
| EBIT 1 | 1,443 | 1,571 | 1,849 | 2,027 | 2,039 | 2,337 | 2,588 | 2,871 |
| Net income 1 | 376 | 335 | 974 | 1,018 | 980 | 792.6 | 1,332 | 1,625 |
| Net Debt 1 | 2,911 | 3,700 | 3,600 | 2,800 | 3,210 | 2,575 | 1,485 | 27.77 |
| Reference price 2 | 88.32 | 68.33 | 77.95 | 84.78 | 80.04 | 63.72 | 63.72 | 63.72 |
| Nbr of stocks (in thousands) | 490,100 | 491,700 | 493,200 | 494,600 | 491,200 | 483,400 | - | - |
| Announcement Date | 2/15/22 | 2/27/23 | 2/27/24 | 2/25/25 | 2/24/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 27.63x | 3.84x | 14.83x | 2.64% | 169B | ||
| 18.25x | 3.37x | 12.04x | 3.26% | 110B | ||
| 21.42x | 4.21x | 14.72x | 1.31% | 106B | ||
| 25.26x | 2.48x | 10.04x | 2.86% | 73.87B | ||
| 16.92x | 0.2x | 12.42x | 0.77% | 58.98B | ||
| 29.48x | 7.29x | 18.84x | 1.36% | 51.28B | ||
| 34.07x | 3.32x | 11.38x | 2.22% | 48.16B | ||
| 35.11x | 8.73x | 24.55x | -.--% | 40.84B | ||
| 34.3x | 6.01x | 18.87x | -.--% | 32.21B | ||
| Average | 26.94x | 4.38x | 15.30x | 1.6% | 76.69B | |
| Weighted average by Cap. | 25.35x | 3.98x | 14.47x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ALC Stock
- A2LC34 Stock
- Valuation Alcon Inc.
Select your edition
All financial news and data tailored to specific country editions
















